DJIA 17,826.30 -279.47 -1.54%
NASDAQ 4,931.82 -75.98 -1.52%
S&P 500 2,081.18 -23.81 -1.13%
market minute promo

Medivation, Inc. (NASDAQ: MDVN)



company name or ticker

Thursday's ETF with Unusual Volume: MTUM

MDVN March 6th Options Begin Trading

Medivation (MDVN) Weak On High Volume Today

Johnson & Johnson Finding Growth A Little Harder Now

Johnson & Johnson Overcomes Threats from Competitors, Delivers Solid Quarterly Results

Revenue and earnings climbed during the fourth quarter on an operational basis.

Why Medivation Inc. Stock Sank 14% in December

Medivation shares plunge in December on fears of a price war breaking out between cancer drug developers. Find out if this dip is worth buying.

Barclays Analyst Sees Biotech FY15 EPS Growth Outstripping Market

UPDATE: Barclays Capital Initiates Coverage On Medivation On Multiple Upside Drivers

These 3 Biotechs Are Looking at a Happy New Year

Which drugs are poised to carry their makers into a healthy 2015? Industry Focus has three top picks.

Noteworthy ETF Outflows: VB, MDVN, COO, ALKS

See More Articles...